Barbara S. Rauckman
Barbara S. Rauckman publishes mostly in Organic Chemistry, Molecular Biology and Physiology, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Biological Evaluation and Synthesis and biological activity.
- World rank
- #4,410,546 of 7,710,434 ranked researchers
- Rank in United States
- #1,178,721 of 1,627,098
- Works
- 29
- Citations
- 566
- Citations per work
- 19.5
What does Barbara S. Rauckman research?
Barbara S. Rauckman's work is mostly in Chemistry (79%), Biochemistry, Genetics and Molecular Biology (16%), Agricultural and Biological Sciences (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- 1Organic Chemistry78% of their works
- 2Molecular Biology13% of their works
- 3Physiology4% of their works
- 4Ecology, Evolution, Behavior and Systematics2% of their works
- 5Spectroscopy1% of their works
- 6Toxicology1% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Synthesis and Reactions of Organic Compounds
- Phenothiazines and Benzothiazines Synthesis and Activities
- Sphingolipid Metabolism and Signaling
- Synthesis of heterocyclic compounds
- Chemical Synthesis and Analysis
Which keywords describe Barbara S. Rauckman's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Heterocycles, Heterocyclic Compounds, Medicinal Chemistry, Anticancer, Antimicrobial and Catalyst.
- Foldamers
- Sphingolipids
- Annulation
- Biological Activities
- Imidazoles
- Tubulin Inhibitors
- Antimicrobial Activity
- Scaffold
- Catalyst
- Anticancer
- Heterocyclic Compounds
- Biological Evaluation
- Synthesis
- Heterocycles
- Medicinal Chemistry
- Antimicrobial
- Drug Discovery
- Triazines
- Quinoxaline
- Vascular Targeting Agents
- Oxazolones
- Phenothiazines
- Ketene Dithioacetal
- Sphingosine-1-Phosphate
- Peptide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Synthesis465 topics
- Biological Evaluation302 topics
- Heterocycles303 topics
- Heterocyclic Compounds232 topics
- Medicinal Chemistry232 topics
- Anticancer222 topics
- Antimicrobial222 topics
- Catalyst212 topics
- Drug Discovery202 topics
- Scaffold181 topic
- Triazines181 topic
- Antimicrobial Activity121 topic
- Quinoxaline121 topic
- Tubulin Inhibitors111 topic
- Vascular Targeting Agents111 topic
- Imidazoles91 topic
- Oxazolones91 topic
- Biological Activities41 topic
- Phenothiazines41 topic
- Annulation31 topic
- Ketene Dithioacetal31 topic
- Sphingolipids31 topic
- Sphingosine-1-Phosphate31 topic
- Foldamers21 topic
- Peptide Synthesis21 topic
Where does Barbara S. Rauckman work?
Barbara S. Rauckman's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does Barbara S. Rauckman have?
OpenAlex counts 29 works and 566 citations for Barbara S. Rauckman, an h-index of 10, ranking #4,410,546 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Barbara S. Rauckman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.